☆ 4.6 Correction

An Oxazole-Based Smati-Motecule Stat3 Inhibitor Modulates Stat3 Stability and Processing and Induces Antitumor Cell Effects (vol 2, pg 787, 2007)

ACS CHEMICAL BIOLOGY (2009)

期刊

ACS CHEMICAL BIOLOGY

卷 4, 期 4, 页码 309-309

出版社

AMER CHEMICAL SOC

DOI: 10.1021/cb9000684

关键词

-

类别

Biochemistry & Molecular Biology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Acacetin Inhibits the Growth of STAT3-Activated DU145 Prostate Cancer Cells by Directly Binding to Signal Transducer and Activator of Transcription 3 (STAT3)

Sun Yun, Yu-Jin Lee, Jiyeon Choi, Nam Doo Kim, Dong Cho Han, Byoung-Mog Kwon

Summary: STAT3 is a crucial factor in the formation and growth of cancer cells, and acacetin inhibits its activity by directly binding to it, leading to inhibition of phosphorylation and nuclear translocation of STAT3, resulting in apoptosis. Interestingly, the inhibition of STAT3 activation by acacetin is independent of reactive oxygen species production.

MOLECULES (2021)

添加到收藏夹

Article Chemistry, Medicinal

Structure-Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway Inhibitors

Zirui Lu, Xiaona Li, Kebin Li, Cong Wang, Tingting Du, Wei Huang, Ming Ji, Changhong Li, Fengrong Xu, Ping Xu, Yan Niu

Summary: Nitazoxanide was identified as a moderate inhibitor of the STAT3 pathway, leading to the design and synthesis of a series of thiazolide derivatives with enhanced potency. Two derivatives, 15 and 24, showed greater efficacy than the positive control WP1066, indicating a potential broad-spectrum effect of thiazolides as antitumor agents targeting STAT3.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells

Xiang Chen, Li Pan, Jia Wei, Ruijie Zhang, Xiaozhi Yang, Jinhua Song, Ren-Yuan Bai, Shengling Fu, Christopher R. Pierson, Jonathan L. Finlay, Chenglong Li, Jiayuh Lin

Summary: The study found that LLL12B is a novel therapeutic agent for medulloblastoma, inhibiting tumor growth by targeting the STAT3 signaling pathway. Combining LLL12B with cisplatin can enhance efficacy for medulloblastoma therapy.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Chemistry, Medicinal

A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling

Dong-Ping Wang, Li-Hong Wu, Rui Li, Na He, Qian-Yue Zhang, Chen-Yang Zhao, Tao Jiang

Summary: The JAK/STAT3 signaling pathway is hyperactivated in many cancers, and inhibitors targeting this pathway have great potential for cancer treatment. In this study, we modified aldisine derivatives by introducing the isothiouronium group, which improved their antitumor activity. Through high-throughput screening, we identified compound 11c as a potent inhibitor of JAK/STAT3 activities. Further experiments showed that compound 11c effectively inhibited STAT3 activation and induced apoptosis in cancer cells. In an in vivo tumor xenograft experiment, compound 11c demonstrated significant antitumor effects.

MARINE DRUGS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Dietary iron modulates gut microbiota and induces SLPI secretion to promote colorectal tumorigenesis

Chen Liu, Junli Gong, Qiang Zhang, Guangyuan Chen, Shengmei Yin, Zhanhao Luo, Wanyi Zeng, Jing Yu, Ping Lan, Zhen He

Summary: This study demonstrates that excessive dietary iron intake perturbs diet-microbiota-epithelium interactions, leading to the initiation of intestinal tumors. The gut microbiota modulated by excessive dietary iron promotes colorectal tumorigenesis by increasing the permeability of the gut barrier and causing leakage of lumen bacteria. Epithelial cells respond to the leaked bacteria by releasing more secretory leukocyte protease inhibitor (SLPI), which acts as a pro-tumorigenic factor by activating the MAPK signaling pathway. Furthermore, the depletion of Akkermansiaceae in the gut microbiota due to excessive dietary iron can be attenuated by supplementation with Akkermansia muciniphila.

GUT MICROBES (2023)

添加到收藏夹

Article Endocrinology & Metabolism

STAT3 Regulates Mitochondrial Gene Expression in Pancreatic β-Cells and Its Deficiency Induces Glucose Intolerance in Obesity

Anais Schaschkow, Lokman Pang, Valerie Vandenbempt, Bernat Elvira, Sara A. Litwak, Beata Vekeriotaite, Elisa Maillard, Marjorie Vermeersch, Flavia M. M. Paula, Michel Pinget, David Perez-Morga, Daniel J. Gough, Esteban N. Gurzov

Summary: This study suggests that STAT3 may be a novel regulator of beta-cell function in obesity, with its deficiency leading to impaired glucose tolerance and reduced expression of mitochondrial genes.

DIABETES (2021)

添加到收藏夹

Article Cell Biology

S1PR1 induces metabolic reprogramming of ceramide in vascular endothelial cells, affecting hepatocellular carcinoma angiogenesis and progression

Xuehong Wang, Zhidong Qiu, Wei Dong, Zebin Yang, Junnan Wang, Hailiang Xu, Tian Sun, Zhaoquan Huang, Junfei Jin

Summary: S1PR1 is highly expressed in the blood vessels of hepatocellular carcinoma (HCC) tissues and promotes angiogenesis by upregulating the expression of proangiogenic factors. It also inhibits CerS3 transcription by inducing CerS6 nuclear translocation. Lenvatinib downregulates S1PR1 expression and enhances its knockdown-mediated angiogenesis inhibition, making it a potential therapy for HCC.

CELL DEATH & DISEASE (2022)

添加到收藏夹

Article Cell Biology

KS10076, a chelator for redox-active metal ions, induces ROS-mediated STAT3 degradation in autophagic cell death and eliminates ALDH1+ stem cells

Jaehee Kim, Areum Park, Jieon Hwang, Xianghua Zhao, Jaesung Kwak, Hyun Woo Kim, Minhee Ku, Jaemoon Yang, Tae Il Kim, Kyu-Sung Jeong, Uyeong Choi, Hyuk Lee, Sang Joon Shin

Summary: Redox-active metal ions play a crucial role in cancer metabolism and proliferation, making metal chelation an attractive strategy for targeting cancer cells. The metal chelator KS10076 is identified as a potent anti-cancer drug candidate that induces reactive oxygen species (ROS) and leads to cell death. KS10076 shows selective targeting towards cancer cells with increased mitochondrial function and is effective against cancer cells with active KRAS and fluorouracil resistance.

CELL REPORTS (2022)

添加到收藏夹

Article Oncology

Palbociclib Induces the Apoptosis of Lung Squamous Cell Carcinoma Cells via RB-Independent STAT3 Phosphorylation

Wenjing Xiang, Wanchen Qi, Huayu Li, Jia Sun, Chao Dong, Haojie Ou, Bing Liu

Summary: The study found that palbociclib induces apoptosis in lung squamous cell carcinoma (LUSC) cells through the inhibition of Src/STAT3 axis, independent of the classic CDK4/6-RB signaling pathway. Palbociclib also suppresses the expression of IL-1β and IL-6, and blocks Src/STAT3 signaling. The sensitivity of LUSC cells to palbociclib is mediated by MYC.

CURRENT ONCOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

LLL12B, a Novel Small-Molecule STAT3 Inhibitor, Induces Apoptosis and Suppresses Cell Migration and Tumor Growth in Triple-Negative Breast Cancer Cells

Li Pan, Xiang Chen, Feyruz Virgilia Rassool, Chenglong Li, Jiayuh Lin

Summary: Persistent STAT3 signaling plays a crucial role in TNBC, and LLL12B inhibitor selectively inhibits STAT3 phosphorylation, inducing apoptosis, reducing colony formation ability, and inhibiting migration.

BIOMEDICINES (2022)

添加到收藏夹

Article Plant Sciences

Apple vacuolar processing enzyme 4 is regulated by cysteine protease inhibitor and modulates fruit disease resistance

Chaohua Dong, Ronghui Li, Nan Wang, Yingshuang Liu, Yugang Zhang, Suhua Bai

Summary: Infection of apple fruits by Botryosphaeria dothidea activates MdVPE4, which is regulated by MdCPI1, to modulate disease resistance. MdVPE4 influences the expression of disease resistance-related genes in apple fruits, while MdCPI1 interacts with MdVPE4 and inhibits its activity. These findings highlight the importance of the interaction between MdVPE4 and MdCPI1 in modulating fruit disease resistance to B. dothidea.

JOURNAL OF EXPERIMENTAL BOTANY (2022)

添加到收藏夹

Article Physiology

Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes

Linxin Xu, Chaofei Xu, Xiangyang Liu, Xiaoyu Li, Ting Li, Xiaochen Yu, Mei Xue, Jing Yang, Constantine E. Kosmas, Dimitrios Moris, Fabian Sanchis-Gomar, Naofumi Yoshida, Nathan A. Berger, Wilbert S. Aronow, Bei Sun, Liming Chen

Summary: Empagliflozin induces white adipose tissue browning and mitochondrial alterations in KKAy mice through activation of AMPK signaling and upregulation of PGC-1α, leading to bodyweight reduction and improved mitochondrial function.

FRONTIERS IN PHYSIOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Remifentanil modulates the TLR4-mediated MMP-9/TIMP1 balance and NF-κB/STAT3 signaling in LPS-induced A549 cells

Jun Chang, Wei Zhang

Summary: Remifentanil can reduce inflammation and oxidative stress, promote cell viability, and inhibit apoptosis in LPS-treated A549 cells, by modulating TLR4 and NF-kappa B/STAT3 signaling pathways to regulate MMP-9/TIMP1 balance. This suggests that remifentanil may have potential therapeutic effects in alleviating acute lung injury.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2023)

添加到收藏夹

Article Oncology

A Benzenesulfonamide-Based Mitochondrial Uncoupler Induces Endoplasmic Reticulum Stress and Immunogenic Cell Death in Epithelial Ovarian Cancer

Fangfang Bi, Ziyan Jiang, Wonmin Park, Tobias M. P. Hartwich, Zhiping Ge, Kay Y. Chong, Kevin Yang, Madeline J. Morrison, Dongin Kim, Jaeyeon Kim, Wen Zhang, Liliia M. Kril, David S. Watt, Chunming Liu, Yang Yang-Hartwich

Summary: The study demonstrated that a mitochondrial uncoupler, Y3, showed antineoplastic effects in ovarian cancer models by activating essential pathways, inhibiting tumor growth and inducing apoptosis in vitro, as well as effectively suppressing tumor progression in vivo. These findings suggest that mitochondrial uncouplers hold promise in developing new anticancer therapies that delay tumor progression and protect patients with ovarian cancer against relapse.

MOLECULAR CANCER THERAPEUTICS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

An Fc-muted bispecific antibody targeting PD-L1 and 4-1BB induces antitumor immune activity in colorectal cancer without systemic toxicity

Lian-sheng Cheng, Min Zhu, Yan Gao, Wen-ting Liu, Wu Yin, Pengfei Zhou, Zhongliang Zhu, Liwen Niu, Xiaoli Zeng, Dayan Zhang, Qing Fang, Fengrong Wang, Qun Zhao, Yan Zhang, Guodong Shen

Summary: Researchers have successfully generated a new immunostimulatory molecule, HK010, which can simultaneously block the PD-1/PD-L1 signaling pathway and activate the 4-1BB signaling pathway. It exhibits synergistic antitumor effects and strictly depends on the PD-L1 receptor without systemic toxicity.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2023)

添加到收藏夹

Editorial Material Multidisciplinary Sciences

Less than the sum of its parts, a leinamycin precursor has superior properties

William P. Katt, Richard A. Cerione

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Design and evaluation of novel glutaminase inhibitors

Lee A. McDermott, Prema Iyer, Larry Vernetti, Shawn Rimer, Jingran Sun, Melissa Boby, Tianyi Yang, Michael Fioravanti, Jason O'Neill, Liwei Wang, Dylan Drakes, William Katt, Qingqiu Huang, Richard Cerione

BIOORGANIC & MEDICINAL CHEMISTRY (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Mechanistic Basis of Glutaminase Activation A KEY ENZYME THAT PROMOTES GLUTAMINE METABOLISM IN CANCER CELLS

Yunxing Li, Jon W. Erickson, Clint A. Stalnecker, William P. Katt, Qingqiu Huang, Richard A. Cerione, Sekar Ramachandran

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

添加到收藏夹

Review Chemistry, Medicinal

A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis

William P. Katt, Michael J. Lukey, Richard A. Cerione

FUTURE MEDICINAL CHEMISTRY (2017)

添加到收藏夹

Editorial Material Oncology

Targeting Therapy Resistance: When Glutamine Catabolism Becomes Essential

Michael J. Lukey, William P. Katt, Richard A. Cerione

CANCER CELL (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

The diamond anniversary of tissue transglutaminase: a protein of many talents

William P. Katt, Marc A. Antonyak, Richard A. Cerione

DRUG DISCOVERY TODAY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism

Qingqiu Huang, Clint Stalnecker, Chengliang Zhang, Lee A. McDermott, Prema Iyer, Jason O'Neill, Shawn Reimer, Richard A. Cerione, William P. Katt

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Glutaminase regulation in cancer cells: a druggable chain of events

William P. Katt, Richard A. Cerione

DRUG DISCOVERY TODAY (2014)

添加到收藏夹

Article Chemistry, Medicinal

Structure-Based Design and Synthesis of Potent, Ethylenediamine-Based, Mammalian Farnesyltransferase Inhibitors as Anticancer Agents

Steven Fletcher, Erin Pusateri Keaney, Christopher G. Cummings, Michelle A. Blaskovich, Michael A. Hast, Matthew P. Glenn, Sung-Youn Chang, Cynthia J. Bucher, Ryan J. Floyd, William P. Katt, Michael H. Gelb, Wesley C. Van Voorhis, Lorena S. Beese, Said M. Sebti, Andrew D. Hamilton

JOURNAL OF MEDICINAL CHEMISTRY (2010)

添加到收藏夹

Article Oncology

Dibenzophenanthridines as Inhibitors of Glutaminase C and Cancer Cell Proliferation

William P. Katt, Sekar Ramachandran, Jon W. Erickson, Richard A. Cerione

MOLECULAR CANCER THERAPEUTICS (2012)

添加到收藏夹

Article Medicine, Research & Experimental

Simultaneously Targeting Tissue Transglutaminase and Kidney Type Glutaminase Sensitizes Cancer Cells to Acid Toxicity and Offers New Opportunities for Therapeutic Intervention

William P. Katt, Marc A. Antonyak, Richard A. Cerione

MOLECULAR PHARMACEUTICS (2015)

添加到收藏夹

Review Multidisciplinary Sciences

Synthetic mimetics of protein secondary structure domains

Nathan T. Ross, William P. Katt, Andrew D. Hamilton

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2010)

添加到收藏夹

Article Chemistry, Multidisciplinary

Amorphous Quantum Nanomaterials

Ferdinand F. E. Kohle, Joshua A. Hinckley, Songying Li, Nikhil Dhawan, William P. Katt, Jacob A. Erstling, Ulrike Werner-Zwanziger, Josef Zwanziger, Richard A. Cerione, Ulrich B. Wiesner

ADVANCED MATERIALS (2019)

添加到收藏夹

Editorial Material Medicine, General & Internal

A unique metabolic dependency for liver cancer stem cells

William P. Katt

EBIOMEDICINE (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Targeting amino acid metabolism for cancer therapy

Michael J. Lukey, William P. Katt, Richard A. Cerione

DRUG DISCOVERY TODAY (2017)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.